<!DOCTYPE html>
<html lang="en">
<head>
 <meta charset="UTF-8">
 <meta name="viewport" content="width=device-width, initial-scale=1.0">
 <title>Lesson 6: Evolution: Long-term Longevity & Cardiovascular Protection | AccrediPro</title>
 <link href="https://fonts.googleapis.com/css2?family=Inter:wght@400;500;600;700;800&display=swap" rel="stylesheet">
 <style>
/* ===========================================
 ACCREDIPRO GOLD STANDARD - UNIFIED LESSON CSS v5.0
 School-Quality ‚Ä¢ ASI Certified ‚Ä¢ Premium UX
 =========================================== */

/* Reset & Base */
* {
 box-sizing: border-box;
 margin: 0;
 padding: 0;
}

body {
 font-family: 'Inter', -apple-system, BlinkMacSystemFont, sans-serif;
 line-height: 1.8;
 color: #1f2937;
 background: #ffffff;
 font-size: 17px;
}

/* MAIN WRAPPER */
.lesson-wrapper {
 max-width: 1200px;
 margin: 0 auto;
 padding: 40px 20px;
}

/* HEADER CARD - Premium Gradient */
.module-header-card {
 background: linear-gradient(135deg, #722F37 0%, #722F37 50%, #5a252b 100%);
 padding: 48px 40px;
 margin-bottom: 40px;
 border-radius: 24px;
 box-shadow: 0 20px 60px -15px rgba(114, 47, 55, 0.4);
 border: none;
 text-align: center;
 position: relative;
 overflow: hidden;
}

.module-header-card::before {
 content: '';
 position: absolute;
 top: -50%;
 left: -50%;
 width: 200%;
 height: 200%;
 background: radial-gradient(circle, rgba(255, 255, 255, 0.05) 0%, transparent 70%);
 pointer-events: none;
}

.module-label {
 font-size: 12px;
 text-transform: uppercase;
 letter-spacing: 3px;
 color: rgba(255, 255, 255, 0.8);
 margin-bottom: 12px;
 font-weight: 600;
 display: block;
}

.lesson-title {
 font-size: 38px;
 color: #ffffff;
 font-weight: 800;
 margin: 0 0 20px 0;
 line-height: 1.15;
 text-shadow: 0 2px 4px rgba(0, 0, 0, 0.1);
}

/* META BADGES */
.lesson-meta {
 display: flex;
 justify-content: center;
 gap: 12px;
 flex-wrap: wrap;
}

.meta-badge {
 background: rgba(255, 255, 255, 0.15);
 color: white;
 padding: 8px 18px;
 border-radius: 24px;
 font-size: 13px;
 font-weight: 600;
 backdrop-filter: blur(8px);
 display: flex;
 align-items: center;
 gap: 6px;
}

/* ASI CREDENTIAL STRIP */
.asi-credential-strip {
 background: linear-gradient(90deg, #f8f5f0, #fffbeb, #f8f5f0);
 border: 1px solid #e5d9c3;
 border-radius: 12px;
 padding: 16px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.asi-logo {
 width: 48px;
 height: 48px;
 background: linear-gradient(135deg, #B8860B, #D4A813);
 border-radius: 10px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 24px;
 color: white;
 flex-shrink: 0;
 box-shadow: 0 4px 12px rgba(184, 134, 11, 0.25);
}

.asi-text .label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1px;
 color: #92400e;
 font-weight: 700;
}

.asi-text .title {
 font-size: 15px;
 color: #78350f;
 font-weight: 600;
 margin-top: 2px;
}

/* TABLE OF CONTENTS */
.toc-box {
 background: #fdf2f4;
 border-radius: 16px;
 padding: 24px;
 margin-bottom: 40px;
}

.toc-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #722F37;
 font-weight: 700;
 margin-bottom: 16px;
 display: block;
}

.toc-list {
 list-style: none;
 display: grid;
 grid-template-columns: repeat(auto-fit, minmax(250px, 1fr));
 gap: 12px;
}

.toc-list li a {
 display: flex;
 align-items: center;
 gap: 10px;
 text-decoration: none;
 color: #374151;
 font-size: 14px;
 font-weight: 500;
 transition: all 0.2s;
}

.toc-list li a:hover {
 color: #722F37;
}

.section-num {
 background: #722F37;
 color: white;
 width: 24px;
 height: 24px;
 border-radius: 6px;
 display: flex;
 align-items: center;
 justify-content: center;
 font-size: 11px;
 font-weight: 700;
}

/* BOXES */
.welcome-box {
 background: #fdf2f4;
 padding: 28px;
 margin-bottom: 40px;
 border-radius: 16px;
 border-left: 5px solid #722F37;
}

.objectives-box {
 background: linear-gradient(135deg, #faf5ff 0%, #f3e8ff 100%);
 border-radius: 16px;
 padding: 28px;
 margin-bottom: 40px;
 border: 1px solid #e9d5ff;
}

.box-label {
 font-weight: 700;
 color: #722F37;
 text-transform: uppercase;
 letter-spacing: 1px;
 font-size: 12px;
 margin-bottom: 16px;
 display: block;
}

/* TYPOGRAPHY */
h2 {
 color: #722F37;
 font-size: 28px;
 margin: 56px 0 24px 0;
 font-weight: 800;
 position: relative;
 padding-bottom: 16px;
}

h2::after {
 content: '';
 position: absolute;
 bottom: 0;
 left: 0;
 width: 60px;
 height: 4px;
 background: linear-gradient(90deg, #B8860B, #D4A813);
 border-radius: 2px;
}

h3 {
 color: #722F37;
 font-size: 22px;
 margin: 36px 0 16px 0;
 font-weight: 700;
}

.highlight {
 background: #fdf2f4;
 color: #722F37;
 padding: 2px 4px;
 border-radius: 4px;
 font-weight: 600;
}

/* COACH TIP */
.coach-tip {
 background: linear-gradient(135deg, #fefce8 0%, #fef9c3 100%);
 border: 1px solid #fde047;
 border-radius: 16px;
 padding: 24px 28px;
 margin: 32px 0;
 position: relative;
}

.tip-label {
 font-size: 11px;
 text-transform: uppercase;
 letter-spacing: 1.5px;
 color: #a16207;
 font-weight: 700;
 margin-bottom: 8px;
 display: block;
}

/* DATA TABLE */
.data-table { width: 100%; border-collapse: collapse; margin: 25px 0; font-size: 15px; }
.data-table th { background: #722F37; color: white; padding: 12px 15px; text-align: left; }
.data-table td { padding: 12px 15px; border-bottom: 1px solid #e5e7eb; }
.data-table tr:nth-child(even) { background: #f9fafb; }

/* CASE STUDY */
.case-study {
 background: white;
 border-radius: 20px;
 margin: 40px 0;
 border: 1px solid #e5e7eb;
 border-left: 5px solid #722F37;
 box-shadow: 0 8px 30px rgba(0, 0, 0, 0.06);
 overflow: hidden;
}

.case-study-header {
 background: #722F37;
 padding: 20px 28px;
 color: white;
}

.case-study-content {
 padding: 28px;
}

/* CHECK UNDERSTANDING */
.check-understanding {
 background: #fdfbf7;
 border: 2px solid #B8860B;
 border-radius: 16px;
 padding: 35px;
 margin: 50px 0;
}
.check-understanding .box-label {
 font-weight: 700;
 color: #8B6914;
 margin-bottom: 25px;
 font-size: 14px;
 text-transform: uppercase;
 letter-spacing: 2px;
 text-align: center;
}
.question-item {
 background: white;
 padding: 25px;
 border-radius: 12px;
 margin-bottom: 20px;
 border: 1px solid #e5e7eb;
}
.reveal-btn {
 background: #722F37;
 color: white;
 border: none;
 padding: 12px 24px;
 border-radius: 8px;
 cursor: pointer;
 font-weight: 600;
 margin-top: 15px;
}
.answer-text {
 display: none;
 margin-top: 20px;
 padding: 20px;
 background: #fdf2f4;
 border-radius: 8px;
 color: #722F37;
 font-size: 16px;
 border-left: 4px solid #722F37;
}

/* TAKEAWAYS */
.takeaways-box {
 background: #722F37;
 color: #ffffff;
 padding: 35px;
 border-radius: 16px;
 margin-top: 60px;
}
.takeaways-box .box-label {
 color: #B8860B;
 font-weight: 700;
 margin-bottom: 20px;
 text-transform: uppercase;
 letter-spacing: 2px;
 font-size: 14px;
}
.takeaways-box ul {
 margin: 0;
 padding-left: 20px;
}
.takeaways-box li {
 margin-bottom: 12px;
 color: #ffffff;
}

/* REFERENCES */
.references-box {
 background: #f8fafc;
 border: 1px solid #e2e8f0;
 border-radius: 16px;
 padding: 32px;
 margin-top: 48px;
}

.references-box ol {
 padding-left: 20px;
}

.references-box li {
 font-size: 14px;
 margin-bottom: 12px;
 color: #475569;
}

.stat-highlight {
 color: #722F37;
 font-weight: 700;
}

.module-connection {
 background: #f0f9ff;
 border: 1px solid #7dd3fc;
 border-radius: 16px;
 padding: 20px 24px;
 margin-bottom: 32px;
 display: flex;
 align-items: center;
 gap: 16px;
}

.connection-text p {
 margin: 0;
 font-size: 15px;
 color: #0c4a6e;
}
 </style>
</head>
<body>

<div class="lesson-wrapper">
 <!-- Module Header Card -->
 <div class="module-header-card">
 <span class="module-label">Module 18: L2: Integration & Synthesis</span>
 <h1 class="lesson-title">Evolution: Long-term Longevity & Cardiovascular Protection</h1>
 <div class="lesson-meta">
 <span class="meta-badge">‚è±Ô∏è 15 min read</span>
 <span class="meta-badge">Lesson 6 of 8</span>
 </div>
 </div>

 <!-- ASI Credential Strip -->
 <div class="asi-credential-strip">
 <div class="asi-logo">ASI</div>
 <div class="asi-text">
 <div class="label">Credential Verification</div>
 <div class="title">AccrediPro Standards Institute Verified Content</div>
 </div>
 </div>

 <!-- Table of Contents -->
 <nav class="toc-box">
 <span class="toc-label">In This Lesson</span>
 <ul class="toc-list">
 <li><a href="#window"><span class="section-num">01</span>The 'Window of Opportunity'</a></li>
 <li><a href="#lipids"><span class="section-num">02</span>Advanced Lipid Synthesis</a></li>
 <li><a href="#cognitive"><span class="section-num">03</span>Cognitive Reserve Strategies</a></li>
 <li><a href="#roadmap"><span class="section-num">04</span>The 20-Year Vitality Roadmap</a></li>
 <li><a href="#biomarkers"><span class="section-num">05</span>Longevity Success Metrics</a></li>
 </ul>
 </nav>

 <!-- Module Connection -->
 <div class="module-connection">
 <div class="connection-text">
 <p><strong>Module Connection:</strong> Having mastered stabilization in the previous lesson, we now pivot to the <strong>Evolve</strong> pillar of the P.H.A.S.E. Framework‚Ñ¢, focusing on the architectural shift from symptom management to 20-year cardiovascular and cognitive protection.</p>
 </div>
 </div>

 <!-- Welcome Box -->
 <div class="welcome-box">
 <p>Welcome to Lesson 6. In the <strong>Evolve</strong> stage, we shift our perspective from the "firefighting" of perimenopausal symptoms to the "architecture" of a long, vibrant life. For women in their 40s and 50s, this is the most critical decade for intervention. We aren't just looking at the next six months; we are looking at the next thirty years. You will learn how to synthesize complex lipid data and cognitive risk factors into a cohesive longevity plan that provides your clients with genuine protection against the "Four Horsemen" of aging.</p>
 </div>

 <!-- Learning Objectives -->
 <div class="objectives-box">
 <span class="box-label">Learning Objectives</span>
 <ul>
 <li>Evaluate the <strong>Window of Opportunity Hypothesis</strong> regarding Menopausal Hormone Therapy (MHT) and cardiovascular health.</li>
 <li>Interpret advanced lipid markers, specifically <strong>ApoB and LDL-p</strong>, to assess actual cardiovascular risk in post-menopausal women.</li>
 <li>Design "Evolve" strategies to build <strong>Cognitive Reserve</strong> and mitigate Alzheimer‚Äôs risk through metabolic stabilization.</li>
 <li>Synthesize a <strong>20-Year Vitality Roadmap</strong> that transitions clients from acute care to long-term longevity.</li>
 <li>Track and analyze <strong>Longevity Biomarkers</strong> including Grip Strength and IGF-1 as success metrics for the PHASE Framework‚Ñ¢.</li>
 </ul>
 </div>

 <h2 id="window">The 'Window of Opportunity' Hypothesis</h2>
 <p>In the world of midlife health, timing is not just a factor‚Äîit is the <strong>primary</strong> factor. The <span class="highlight">Window of Opportunity Hypothesis</span> suggests that the beneficial effects of estrogen on the cardiovascular system and the brain are highly dependent on the age of the woman and the time since the onset of menopause.</p>

 <p>Estrogen is naturally vasoprotective; it promotes nitric oxide production and maintains arterial elasticity. However, when a woman has been estrogen-deficient for more than 10 years, or is over the age of 60, the "window" begins to close. Initiating hormone therapy <em>after</em> significant atherosclerosis has developed may actually be pro-thrombotic rather than protective.</p>

 <div class="coach-tip">
 <span class="tip-label">üí° Coach Tip: Career Insight</span>
 <p>As a Menopause Specialist, your ability to explain this "window" is a high-value skill. Practitioners who can navigate these nuances often command <strong>$150 to $250 per hour</strong> for longevity consulting. You are helping women make decisions that will affect their health decades from now.</p>
 </div>

 <h2 id="lipids">Advanced Lipid Synthesis: Beyond LDL-C</h2>
 <p>Standard lipid panels (Total Cholesterol, LDL-C, HDL, Triglycerides) often fail post-menopausal women. After the loss of estrogen, many women see a sharp rise in LDL-C. However, LDL-C only measures the <em>weight</em> of the cholesterol, not the <em>number of particles</em> or their <em>atherogenic potential</em>.</p>

 <p>In the <strong>Evolve</strong> stage, we must look at:</p>
 <ul>
 <li><strong>ApoB (Apolipoprotein B):</strong> This is a measure of the total number of atherogenic particles. A high ApoB is a much more accurate predictor of risk than LDL-C alone.</li>
 <li><strong>LDL-p (LDL Particle Number):</strong> Specifically measures the number of low-density lipoprotein particles. Small, dense LDL particles are more likely to penetrate the arterial wall.</li>
 <li><strong>Lp(a):</strong> A genetically determined marker that increases risk of early heart disease and is often elevated in the post-menopausal transition.</li>
 </ul>

 <table class="data-table">
 <thead>
 <tr>
 <th>Marker</th>
 <th>Standard Range</th>
 <th>Longevity Optimal (Evolve)</th>
 <th>Clinical Significance</th>
 </tr>
 </thead>
 <tbody>
 <tr>
 <td>ApoB</td>
 <td>&lt; 90 mg/dL</td>
 <td>&lt; 65 mg/dL</td>
 <td>Primary driver of plaque formation</td>
 </tr>
 <tr>
 <td>Triglycerides</td>
 <td>&lt; 150 mg/dL</td>
 <td>&lt; 80 mg/dL</td>
 <td>Reflects insulin sensitivity and liver health</td>
 </tr>
 <tr>
 <td>Lp(a)</td>
 <td>&lt; 30 mg/dL</td>
 <td>&lt; 15 mg/dL</td>
 <td>Genetic risk factor for vascular events</td>
 </tr>
 </tbody>
 </table>

 <!-- Case Study -->
 <div class="case-study">
 <div class="case-study-header">
 <strong>Case Study: Sarah (Age 54) - The Silent Shift</strong>
 </div>
 <div class="case-study-content">
 <p><strong>Client:</strong> Sarah, a 54-year-old former teacher, 3 years post-menopause.</p>
 <p><strong>Presenting:</strong> Sarah was "cleared" by her GP despite her LDL-C rising from 110 to 165 mg/dL post-menopause. She felt fine but was worried about her family history of stroke.</p>
 <p><strong>Intervention:</strong> Using the PHASE Framework‚Ñ¢, we ordered an advanced lipid panel. Her <strong>ApoB was 122 mg/dL</strong> (high risk) and her <strong>LDL-p</strong> showed a "Pattern B" (small, dense particles). We implemented the <strong>Evolve</strong> protocol: increased soluble fiber (35g/day), added 2g of high-quality EPA/DHA, and focused on Zone 2 cardiovascular training.</p>
 <p><strong>Outcome:</strong> Six months later, Sarah's ApoB dropped to 88 mg/dL, and her CAC (Coronary Artery Calcium) score remained at zero, providing her with a baseline for her 20-year roadmap.</p>
 </div>
 </div>

 <h2 id="cognitive">Cognitive Reserve: Mitigating Alzheimer‚Äôs Risk</h2>
 <p>Women represent two-thirds of Alzheimer‚Äôs cases. The drop in estrogen during menopause leads to a significant decrease in brain glucose metabolism. If the brain cannot effectively use glucose, and it hasn't been "trained" to use ketones, a <span class="highlight">bioenergetic crisis</span> occurs.</p>

 <p>Building <strong>Cognitive Reserve</strong> involves three "Evolve" pillars:</p>
 <ol>
 <li><strong>Metabolic Flexibility:</strong> Ensuring the brain can switch between glucose and ketones (achieved through intermittent fasting and low-glycemic nutrition).</li>
 <li><strong>Vascular Health:</strong> What is good for the heart is good for the brain. Small vessel disease is a major contributor to cognitive decline.</li>
 <li><strong>Deep Sleep (Stabilize Integration):</strong> The glymphatic system clears beta-amyloid plaques during deep NREM sleep.</li>
 </ol>

 <div class="coach-tip">
 <span class="tip-label">üí° Coach Tip: The "Why"</span>
 <p>When clients resist lifestyle changes, remind them: "We are building your brain's 'savings account.' The more we invest in cognitive reserve now, the more your brain can withstand the natural changes of aging without losing function."</p>
 </div>

 <h2 id="roadmap">The Post-Menopausal Roadmap: 20-Year Vitality</h2>
 <p>Transitioning from "fixing symptoms" to "planning vitality" requires a mindset shift. The <strong>20-Year Roadmap</strong> focuses on three distinct decades:</p>

 <ul>
 <li><strong>The Foundation Decade (Ages 45-55):</strong> Focus on body composition (muscle mass) and metabolic stabilization.</li>
 <li><strong>The Resilience Decade (Ages 55-65):</strong> Focus on bone density and cardiovascular elasticity.</li>
 <li><strong>The Vitality Decade (Ages 65+):</strong> Focus on mobility, balance, and cognitive engagement.</li>
 </ul>

 <p>In the <strong>Evolve</strong> stage, we utilize specific success metrics to ensure the roadmap is on track. A 2023 study found that women with higher midlife grip strength had a <span class="stat-highlight">34% lower risk</span> of all-cause mortality over the following 20 years.</p>

 <h2 id="biomarkers">Longevity Biomarkers: Success Metrics</h2>
 <p>How do we know if our "Evolve" strategies are working? We move beyond the scale and look at functional markers of biological age:</p>

 <ul>
 <li><strong>IGF-1 (Insulin-like Growth Factor 1):</strong> While too much can be pro-growth (cancer risk), too little leads to frailty and poor tissue repair. We look for a "Goldilocks" zone.</li>
 <li><strong>Grip Strength:</strong> A "vital sign" for aging. It correlates directly with muscle mass and nervous system integrity.</li>
 <li><strong>hs-CRP:</strong> A marker of systemic inflammation. In the Evolve stage, we want this <strong>&lt; 1.0 mg/L</strong> to protect the heart and brain.</li>
 <li><strong>HOMA-IR:</strong> Even in non-diabetics, keeping insulin sensitivity high is the "master key" to longevity.</li>
 </ul>

 <div class="coach-tip">
 <span class="tip-label">üí° Coach Tip: Professionalism</span>
 <p>Always remind clients that you are a <strong>Specialist</strong>, not a doctor. You provide the data and lifestyle architecture that they can take to their medical team to refine their clinical care. This collaborative approach is what makes the PHASE Framework‚Ñ¢ so powerful.</p>
 </div>

 <!-- Check Your Understanding -->
 <div class="check-understanding">
 <p class="box-label">Check Your Understanding</p>
 
 <div class="question-item">
 <p class="question-text"><strong>1. What is the primary focus of the 'Window of Opportunity' Hypothesis?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">It suggests that the benefits of Menopausal Hormone Therapy (MHT) for cardiovascular and brain health are greatest when started within 10 years of menopause onset or before age 60, before significant vascular damage has occurred.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>2. Why is ApoB considered a superior marker to LDL-C for cardiovascular risk?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">LDL-C measures the weight of cholesterol, whereas ApoB measures the actual number of atherogenic particles. Since every plaque-forming particle has one ApoB molecule, it provides a more accurate count of the "bullets" that can cause arterial damage.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>3. Which biomarker is considered a "vital sign" for aging and a predictor of all-cause mortality?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">Grip Strength. It serves as a proxy for overall muscle quality, frailty risk, and neurological health in post-menopausal women.</div>
 </div>

 <div class="question-item">
 <p class="question-text"><strong>4. What bioenergetic shift occurs in the brain during the menopause transition?</strong></p>
 <button class="reveal-btn">Reveal Answer</button>
 <div class="answer-text">The brain experiences a decline in glucose metabolism due to the loss of estrogen. Without metabolic flexibility (the ability to use ketones), this can lead to a "bioenergetic crisis" that increases Alzheimer's risk.</div>
 </div>
 </div>

 <!-- Takeaways -->
 <div class="takeaways-box">
 <span class="box-label">Key Takeaways</span>
 <ul>
 <li><strong>Timing is Everything:</strong> Interventions for cardiovascular protection are most effective during the "Window of Opportunity" (early post-menopause).</li>
 <li><strong>Deep Lipid Analysis:</strong> Move beyond standard cholesterol tests to evaluate ApoB and LDL-p for true risk assessment.</li>
 <li><strong>Cognitive Reserve:</strong> Building brain resilience through metabolic flexibility and vascular health is a non-negotiable "Evolve" strategy.</li>
 <li><strong>Functional Metrics:</strong> Use Grip Strength and hs-CRP as tangible markers of longevity success rather than just relying on the scale.</li>
 <li><strong>The 20-Year View:</strong> Shift the coaching conversation from acute symptom relief to long-term vitality architecture.</li>
 </ul>
 </div>

 <!-- References -->
 <div class="references-box">
 <span class="box-label">References & Further Reading</span>
 <ol>
 <li>Manson, J. E., et al. (2023). "The Menopause Transition and Cardiovascular Disease Risk: A Scientific Statement From the American Heart Association." <em>Circulation</em>.</li>
 <li>Brinton, R. D. (2022). "The 'Window of Opportunity' for Estrogen Therapy: Metabolic and Cognitive Implications." <em>Frontiers in Endocrinology</em>.</li>
 <li>Sniderman, A. D., et al. (2021). "Apolipoprotein B vs LDL Cholesterol and Non-HDL Cholesterol as the Primary Measure of Atherogenic Lipoproteins." <em>JAMA Cardiology</em>.</li>
 <li>Bohannon, R. W. (2019). "Grip Strength: An Indispensable Biomarker for Older Adults." <em>Clinical Interventions in Aging</em>.</li>
 <li>Mosconi, L., et al. (2021). "Menopause impacts human brain structure, connectivity, and metabolism." <em>Nature Communications</em>.</li>
 <li>Attia, P. (2023). <em>Outlive: The Science and Art of Longevity</em>. Harmony Books (Clinical application of ApoB/Grip Strength).</li>
 </ol>
 </div>
</div>

<script>
 document.querySelectorAll('.reveal-btn').forEach(button => {
 button.addEventListener('click', function() {
 const answer = this.nextElementSibling;
 if (answer && answer.classList.contains('answer-text')) {
 answer.style.display = answer.style.display === 'none' || answer.style.display === '' ? 'block' : 'none';
 }
 });
 });
</script>

</body>
</html>